SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle is experiencing a sharp sell-off driven by investor concerns over heavy debt loads, massive capital expenditure on AI infrastructure, and a recent credit rating downgrade. Despite this volatility, many in the community are debating whether the current price represents a compelling long-term value opportunity based on a strong revenue backlog or a dangerous falling knife that could see further downside.

Direxion Shares ETF Trust - Direxion Daily MSCI South Korea Bull 3X ETF

Direxion Daily South Korea Bull 3X Shares

KORU is experiencing significant volatility driven by the memory sector's rapid demand shifts and anticipation surrounding an upcoming 20-for-1 stock split. Community discussion is heavily focused on the stock's extreme swings, with some traders viewing the recent sharp pullback as a buying opportunity while others express caution regarding the risks inherent in leveraged ETFs.

SoundHound AI, Inc. engages in the development, owning, and commercialization of voice, sound, and natural language artificial intelligence technologies and related activities. The company was founded by Keyvan Mohajer, Majid Seyed Emami and James M. Hom on September 2, 2005 and is headquartered in Santa Clara, CA.

SoundHound AI Inc - Ordinary Shares - Class A

SoundHound AI Inc

SoundHound AI is experiencing heightened volatility and intense debate as investors weigh strong institutional adoption and Gartner leader recognition against persistent concerns over dilution and profitability. The stock remains a focal point for the community due to its significant short interest and concentrated options positioning, which many traders are watching closely for a potential short-squeeze catalyst as the company continues to advance its LivePerson merger.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

SOXL is currently experiencing high volatility driven by aggressive buying interest following a semiconductor sector sell-off, while investors remain hyper-focused on upcoming memory chip industry catalysts and geopolitical developments. The community is actively debating the sustainability of the AI-driven infrastructure boom versus the potential risks posed by interest rate uncertainty and shifting demand dynamics for memory chips.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

United States Oil Fund is trading in response to a surge in geopolitical tensions, with traders actively monitoring renewed military strikes between the U.S. and Iran and their potential impact on critical shipping corridors. Community sentiment is deeply divided, with many market participants debating whether the conflict signals a long-term supply shock or if geopolitical headlines are being used to manipulate oil prices.

Q32 Bio, Inc. operates as a clinical stage biotechnology company developing biologic therapeutics targeting potent regulators of the innate and adaptive immune systems to re-balance immunity in autoimmune and inflammatory diseases. It focuses on the IL-7 / TSLP receptor pathways and complement system, addressing immune dysregulation to help patients take back control of their lives. The company was founded by David Grayzel and Shelia Violette in 2017 and is headquartered in Waltham, MA.

Q32 Bio Inc.

Q32 Bio is capturing significant attention after reporting positive 36-week clinical trial data for bempikibart in treating alopecia areata. While bulls are celebrating the potential long-term turning point and analyst target upgrades, many community members remain cautious, debating the impact of a recent large-scale public offering and the risk of further dilution.

Conagra Brands, Inc. engages in the manufacture and sale of processed and packaged foods. It operates through the following segments: Grocery and Snacks, Refrigerated and Frozen, International, and Foodservice. The Grocery and Snacks segment includes branded, and shelf stable food products sold in various retail channels in the United States. The Refrigerated and Frozen segment is composed of branded, and temperature-controlled food products sold in various retail channels in the United States. The International segment offers branded food products in various temperature states, sold in various retail and foodservice channels outside of the United States. The Foodservice segment focuses on branded and customized food products, including meals, entrees, sauces, and a variety of custom-manufactured culinary products packaged for sale to restaurants and other foodservice establishments in the United States. The company was founded by Alva Kinney and Frank Little in 1919 and is headquartered in Chicago, IL.

Conagra Brands Inc

Conagra Brands is currently trending due to a leadership transition as the company prepares for a new CEO while navigating heavy institutional selling and ongoing speculation about a potential dividend cut. Community discussion remains polarized, with many investors viewing the stock as a deeply undervalued defensive play at multi-decade price lows, while others express frustration over persistent downtrends and concerns regarding debt levels.

Chipotle Mexican Grill, Inc. engages in the business of developing and operating restaurants that serve a relevant menu of burritos, burrito bowls, quesadillas, tacos, and salads made using fresh, high-quality ingredients. The company was founded by Steve Ells in 1993 and is headquartered in Newport Beach, CA.

Chipotle Mexican Grill

Chipotle is generating buzz as it launches its first restaurant in Mexico, a strategic move aimed at international expansion that has sparked debates over brand identity and growth potential. Investors are actively tracking this development alongside the stock's recent market movement as they weigh the company's long-term scaling strategy against ongoing concerns regarding consumer demand and service consistency.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

The QQQ is facing heightened volatility driven by the reinstatement of a U.S. naval blockade in the Strait of Hormuz, which has sparked geopolitical tension and oil price surges. Investors are actively debating whether this pullback is a healthy consolidation ahead of upcoming CPI data and earnings, or the start of a broader tech sector correction amid concerns over AI valuations and potential Fed interest rate hikes.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride-share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company was founded by Peter Beck in 2006 and is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab is currently the subject of intense community debate as investors weigh the impact of recent insider share sales against strong institutional price targets and the potential of its strategic acquisition of Iridium. While the stock has faced downward pressure alongside the broader space sector following the SpaceX IPO, many traders are closely watching the 200-day moving average as a historically significant support level for long-term accumulation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

OTLK Stock Up 35% as FDA Accepts Resubmitted Eye Drug BLA for Review

Outlook Therapeutics stock surges 35% after the FDA accepts the resubmitted Lytenava BLA for wet AMD for review, setting a July 29, 2026, decision date.

Outlook Therapeutics Eye Drug Review Returns To FDA For Fourth Time

Outlook Therapeutics shares rose after the FDA accepted its resubmitted LYTENAVA BLA and set a July 2026 target action date.read more...

OTLK Stock Soars 28% After FDA Sets July Date For Lytenava Decision

Equity

The agency will now decide whether to approve the drug by July 29, 2026.

OTLK Stock Surges On FDA Lytenava Application Resubmission After Successful Appeal  

A decision on the resubmitted application is expected within 60 days of the FDA’s receipt of it, the company said.


OTLK Stock Rocket Nearly 140%: Lytenava Dispute Resolution With FDA Pushes Stock On Track For Best Week On Record

Outlook Therapeutics wins appeal following formal dispute resolution process for LYTENAVA.

Why RDW, TE, OTLK Stocks Posted Double-Digit Gains On Tuesday

Redwire, T1 Energy, and Outlook Therapeutics shares soared due to broad sectoral optimism, strong institutional backing, and positive company developments, respectively. 

Traders Rush into AI, Biotech, and Emerging Tech

Momentum traders are aggressively rotating into AI infrastructure, biotech catalysts, blockchain exposure, and emerging technology plays as speculative appetite continues heating up across small-cap and high-growth sectors. $KBLB, $OTLK, $PHGE, $UZX, $QTEK $ARTL, $VCIG, $YMAT, $NCRA

Outlook Therapeutics Stock Climbs 38% After Winning FDA Appeal For NAMD Therapy

(RTTNews) - Shares of Outlook Therapeutics, Inc. (OTLK) are climbing about 38 percent in Tuesday morning trading after the company announced that the U.S. FDA has granted its appeal following completion of the Formal Dispute Resolution process for ONS-5010/LYTENAVA, its investiga...

OTLK Stock Surges Over 50% Pre-Market, Breaches Key Technical Milestone – What’s Behind This Massive Rally?

The U.S. Food and Drug Administration granted Outlook Therapeutics its appeal following a formal dispute resolution process related to its eye disease drug Lytenava.

Oncobiologics, Inc. (OTLK) Reports Q2 Loss, Lags Revenue Estimates

Oncobiologics (OTLK) delivered earnings and revenue surprises of -33.33% and -97.09%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

This account has been verified as an official OTLK representative.

Verified Account

Outlook Therapeutics

Outlook Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of ONS-5010/LYTENAVA. Its pipeline includes unmet patient needs, repackaged IV bevacizumab, and anti-VEGF. The company was founded by Pankaj Mohan on January 5, 2010 and is headquartered in Iselin, NJ.

Outlook Therapeutics Inc

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Fiscal Period	Estimated	Reported	Surprise	Result
Q3 '26	-$0.10	--	--	N/A
Q2 '26	-$0.12	-$0.16	-32.05%	MISSED
Q1 '26	-$0.23	-$0.22	2.94%	BEAT
Q4 '25	-$0.23	-$0.06	74.29%	BEAT
Q3 '25	-$0.35	-$0.44	-24.82%	MISSED

Feed

News

Sentiment

Earnings

Fundamentals

Info

OTLKOutlook Therapeutics Inc

Upcoming Earnings: Q3 '26

Historical Earnings

Latest OTLK News